continuity plan

continuity plan

 

Mohannad Gomaa shares an article designed to help you manage supply chain resilience by developing a continuity guide. 

Supply Chain Continuity Plan (SCCP)

Manage your Supply chain resilience and provide the business with a supply chain business continuity plan Business Impact Analysis

External Suppliers and Customers:

Send questionnaires to your suppliers and service providers to see how their operations are adjusting and discuss capacity availability/pricing/contract FM. Conduct meetings on key risk orders/SKUs

Communicate with your customers on key issues and ways to collaborate to fulfill orders and (investment/capacity) support needed. There are lessons learned from Toyota and others on how their supply chain network worked together during suppliers’ emergency shutdowns

Internal Operations:

Leverage your IBP structure to schedule an emergency meeting and discuss demand and supply risks and impact on customers.

Identify what if scenarios and resolutions to be escalated to C-level

 

Key points in this article include:

  • Recovery Strategies
  • Plan Deployment
  • Test Procedures

 

Access the full PDF, Supply Chain Continuity Plan Guide,from mgostrategy.com.

 

Umbrex is pleased to welcome Alex Jacobs-Hajian.  Alex is a C-Level Strategy and Operations Management Consultant focused on Mergers and Acquisitions, Deep Technical Know-How, and Business & Legal Acumen

Functional Expertise:
• Program and Project Management
• Client Relationship Management and Value Realization
• Digital and Technology Strategy
• Lean Six Sigma Certified

Industry Domains:
• Resources and Utilities
• Communications, Media, and Technology
• Healthcare and Life Sciences
• Government and Public Service

Umbrex is pleased to welcome David Edelman. After 30 years as a Chief Marketing Officer (at Aetna/CVS) and building consultancy businesses in Digital and Marketing Transformation (with McKinsey, Digitas, and the Boston Consulting Group), I would love to work with others on helping companies in healthcare, fin services, consumer services, and marketing tech/svcs shape their strategic direction, build their teams’ capabilities, and become more digitally agile. I know what it takes from the top strategic level down to the nitty gritty of tech, ops, and creative to get great marketing done.

I am also open to appropriate opportunities on boards, and am currently on two non-profit boards — The Walnut Hill School for the Arts, and the Boston Ad Club — where I serve on the strategy committees, building a future direction for both institutions to expand their impact.

I’ve published in HBR, speak frequently at industry conferences and events, and blog on topics ranging from digital marketing to the Customer Decision Journey. But most importantly, I am also a music fanatic and play saxophone.

Umbrex is pleased to welcome Seth Townsend with Tonisgah Group. Seth  spent 5 years at McKinsey as part of the Healthcare practice, leading efforts across sales growth, pricing, operations, due diligence, M&A, and corporate strategy for companies in the pharmaceuticals, medical devices, and healthcare industry.  Following his time at McKinsey, Seth worked at Novartis where he held roles in Commercial, Shared Services, Finance, and Operations in both the US and Switzerland.  He was most recently Head of Commercial Support Operations in the Sandoz Division, a global leader in generics and biosimilars where he led a team of over 30 people across insights & analytics, salesforce effectiveness, sales training, and data services. Seth was the SVP Transformation for Beacon Health Options, the largest private behavioral health company with sales of over $2B (now a part of Anthem).  There, he led initiatives across transaction management, margin improvement / value creation, and organizational restructuring.

Seth holds a Global Executive MBA with distinction from INSEAD, a PhD in Biological Engineering from MIT, and a BS in Biomedical Engineering from Johns Hopkins University.  Seth lives with his wife and two daughters in New York.  He would be happy to collaborate on projects in the pharmaceutical, healthcare, and private equity industries.

Umbrex is pleased to welcome Przemek Czerklewicz. Przemek worked as a specialist consultant focused on end-to-end support for M&As in the strategy practice at McKinsey. In 2017 he started his independent consultancy, advising on transactions, technology strategy and innovation.

Przemek has been responsible for over 30 due diligence and acquisition screening studies, both for financial and industrial buyers. Most of his Clients are healthcare institutions, pharmaceuticals, medical devices, as well as high tech and social sector organizations. He has also managed pro bono projects in Eastern Europe and the Middle East, helping rising startups, local producers and farmers.

Umbrex is pleased to welcome Sean Folan.  Sean is a versatile brand growth strategist with deep expertise leveraging insights and analytics to build and activate brand strategies and growth plans for clients in healthcare, consumer products, hospitality, aviation, telecom and financial services. His work has ranged from category and brand creation to product/service innovation, launch planning and campaign development/execution.

Sean and his family live in Connecticut where they enjoy hiking, biking and spending time with friends. He is looking to collaborate on projects involving brand growth strategy development and execution in the US, regionally, or globally.

Umbrex is pleased to welcome Kordt Griepenkerl with Med-Beratung. Kordt  spent five years in the McKinsey healthcare practice in Germany and then worked in leadership positions for the medtech firms Biotronik and Trumpf Medical (now part of Hill-Rom). He covers a wide range of fields from operations to sales and marketing and extensive international experience. He and has been running his own consulting firm  Med-Beratung UG since 2012.

Prior to McKinsey, Kordt obtained this PdD in theoretical physics. He lives in Reutlingen, South of Stuttgart, Germany.

In his spare time, he tries to improve this skill on his trombone and baritone horn as well as getting up to speed, running in the hills behind his house.

Kordt is happy to collaborate on projects in the healthcare industry.

Umbrex is pleased to welcome Ryan Wilber.  Ryan has spent the past 10 years working with healthcare providers to design and implement innovative solutions to pressing care delivery challenges. His experience spans working with small community hospitals, large academic research centers, and integrated multi-hospital systems in the US and internationally to assess and implement new processes and technologies.

While his clients have been varied, his work has had in common a focus on addressing the core provider challenges around access, cost of care, patient experience, and quality. Increasingly, this work has centered on digital and virtual solutions. He believes the most effective solutions to healthcare challenges combine process and culture change with innovation and technology. To that end, he also works with a Bay Area venture fund to assess emerging healthcare technologies and advises their healthcare-focused portfolio companies on how to meet the needs of healthcare providers.

Umbrex is pleased to welcome Christian Frank with Redwood Wellness Partners. Christian Frank spent 8 years at McKinsey in Germany (Automotive, Operations, Sales and Marketing) and the US (HighTech, Healthcare, IT).  After working at IBM in corporate strategy, SMB strategy and Healthcare Business Process Outsourcing he joined ADP as head of corporate strategy and employer services marketing.  Following ADP he founded an employee wellness screening company and has been working as an independent consultant for the past 8 years.

Umbrex is pleased to welcome Jeff Boschwitz with JSB Consulting. Dr. Jeff Boschwitz has spent the last four years as an independent consultant focused on growth/new product and operations strategy for healthcare companies. Prior to that Jeff was COO of Personal Genome Diagnostics, EVP of Operations and Corporate Development at PLUS Diagnostics, VP Sales and Marketing for Orchid Cellmark and Director of Marketing Strategy and Analysis for Quest Diagnostics. Prior to going to industry, Jeff spent 10 years in consulting, the last five at Booz Allen Hamilton where he was a Principal in the healthcare practice.

Jeff received his PhD in Microbiology and Immunology from Cornell University and completed his Post-Doctoral work at Stanford University. He lives near Princeton NJ with his wife and spends his spare time with his racehorses. Jeff specializes in business unit, asset monetization, and cost reduction strategies and is happy to collaborate with anyone pursuing projects of this type for healthcare clients.

Umbrex is pleased to welcome Marla Malluk Gozman.  Marla Malluk Gozman spent nearly ten years at Bain & Company in their Boston, London, and New York City offices. Since then, she has been an independent strategy consultant and also spent three years as Sales Strategy Director with Zearn, a nonprofit education technology organization. Marla has expertise in growth strategy and strategic planning, market and competitive analysis, and pricing, as well as advising start-up and nonprofit organizations. She has experience in many sectors, including health care, education, consumer finance, retail, hospitality, and telecommunications. Marla lives in northern New Jersey with her husband and son. She is happy to collaborate on growth strategy and market/competitive analysis projects in the greater New York City area.

 

Joyjit Saha Choudhury takes a look ahead to determine the effect of COVID-19 on health plans. 

COVID-19 has upended our society, economy and the healthcare ecosystem in particular, and tremendous efforts are underway to try and manage the epidemic. In this difficult and unsettling time, I wanted to help think ahead to actions US-based payors and providers should take for a post-COVID-19 world. 

This piece is structured in three parts – part 1 outlines likely strategic changes to the payor-provider landscape in the near- to medium-term; part 2 serves to remind the industry about what will likely NOT change in the long-term; finally, in light of parts 1 and 2, part 3 lays out six major actions payors and providers should take for a post-COVID-19 world.

 

Areas covered in this article include:

  • Changes in the payor-provider landscape in the near- to medium-term
  • What will not change in the payor-provider landscape in the long-term
  • Actions payors and providers should take for success in a post-COVID-19 world

 

Read the full article, Six Actions U.S. Payors Providers Should Take for a Post COVID-19 World, on LinkedIn.

 

Umbrex is pleased to welcome Tushar Srivastava. Tushar is an independent strategy consultant who started his consulting career at McKinsey where he spent more than 3.5 years working as a generalist, eventually developing a spike in healthcare and life sciences. He has spent more than 3 years working as an Independent with multiple projects in pharma, life sciences, medical technology and healthcare.

Functionally, he is comfortable working on strategy initiatives across R&D, marketing, operations, technology, and pre-sales. He is open to collaborating on projects and supporting (research/analytics) clients without a restriction on geography, he has worked on projects in North America, Europe and APAC.

 

Posted on Jim Price’s company blog is a downloadable white-paper that explores the role of automation in healthcare.

As discussed in Issue One, the future of medicine will be fundamentally reshaped by a fusion of three forces: Genetics, Artificial Intelligence (AI) and automation. The future of interventional and surgical capabilities has not been widely discussed. Demand for these services has risen dramatically in recent years and is forecast to increase significantly in the coming decades. As a result, demand is quickly overtaking supply in surgical and procedural services; however, current payment systems cannot support the labor intensive model. AI, advanced robotics, 5G Internet, 3D printing, miniaturization, and nano technology will eventually fuse together to dramatically automate surgical and procedural services, alleviating the manpower shortage.

 

Included in this paper are:

  • FDA approved AI applications
  • Reimagining the future of surgery
  • The performance of a pre-op robot

 

Download the full paper, Automated Medicine: The Future of Healthcare?, on the Progressive Healthcare Inc. website. 

 

Umbrex is pleased to welcome Brett Pentz. Brett has 12+ years of management consulting and client services experience, delivering a range of strategy engagements for corporate, private equity, and public sector clients across industry, mostly focused in Healthcare and Technology. Brett’s management consulting work spans formative skills and credentials developed at Bain & Company, followed by contributions to position Teneo’s management consulting capabilities to reflect its brand as the global CEO advisory firm. Brett also possesses strong implementation and value delivery credentials from his years as a healthcare software implementation specialist for leading electronic medical record vendor Epic.

Brett primarily focuses on roles and projects where his experience and educational background can add the most value, often serving health and wellness-focused services and technology platform-focused companies, but he has demonstrated successful outcomes as a generalist at Bain and Teneo across a range of industries and project types. Specialties include corporate/BU strategy and planning, sales and marketing effectiveness, commercial due diligence and post-acquisition value creation, and target operating model and organizational design.

Brett lives in Montreal, Canada with his wife, after moving there two years ago from London, England – all part of his American expat adventures. He is happy to collaborate on any projects, particularly in the northeast (of the US and Canada).

Umbrex is pleased to welcome Justin Lechner with Bonsai Growth. Justin Lechner is an ex-Bain consultant based in Brooklyn, NY. After leaving Bain, Justin has split his time between ventures in the enterprise AI space and independent consulting work (innovation and technology projects).

Justin’s particularly passionate about applications of data science within the Consumer, Healthcare, and PE spaces. Justin is excited to collaborate on projects with a data focus